Chronic Fatigue Syndrome Trial, Not Yet Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You can be any sex or gender
- You are 16 years old or older
- You are able to speak and understand English
- You are experiencing memory or thinking problems (at least mild) connected to a confirmed diagnosis such as Long COVID, a traumatic brain injury, another type of acquired brain injury, or a condition like Alzheimer's disease or other similar conditions
- If you are someone who could become pregnant, you are willing to use a highly effective form of birth control for the whole time you are in the study
- You are willing and able to sign a consent form yourself, or have a parent or legal representative sign it on your behalf
- You are able and willing to attend all study appointments, either online or in person
Who may not be able to join:
- You have taken part in another clinical trial involving a treatment or intervention in the last 90 days, or are currently in one
- Your antidepressant or other mental health medication, or its dose, has been changed in the last 90 days
- You have any metal or a medical device implanted in your skull or head
- You have a pacemaker
- You have a history of seizures or a seizure disorder
- You are currently pregnant or plan to become pregnant during the study (a pregnancy test will be used to confirm this)
- The study device cannot be properly fitted or positioned on your head
- You have any medical, mental health, or neurological condition, or are receiving a treatment, that the lead researcher feels could interfere with the study or put you at additional risk (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: David Putrino, PhD, Icahn School of Medicine at Mount Sinai
Phone: 212-241-7658
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of participants who complete prescribed device sessions
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.